FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304203434> ?p ?o ?g. }

• W4304203434 endingPage "375" @default.
• W4304203434 startingPage "363" @default.
• W4304203434 abstract "The first-in-human phase I study for E6742, a dual toll-like receptor (TLR) 7 and TLR8 antagonist, has been conducted to assess the safety, tolerability, and pharmacokinetics of E6742 in healthy volunteers. In a single ascending dose (SAD) study, 42 subjects received 10-800 mg of E6742 in the fasted state, as well as a 100-mg cohort in the fed state for evaluating the effect of food. In a multiple ascending dose (MAD) study, 18 subjects received 100-400 mg of E6742 twice daily for 7 days. E6742 was rapidly absorbed with a median tmax ranging from 1.50 to 2.50 hours across dose groups under the fasted condition, and eliminated with a median t½ ranging from 2.37 to 14.4 hours. After multiple oral doses, a steady state was reached by day 7. In the SAD study, dose proportionality was observed for Cmax , AUC(0-t) , and AUC(0-inf) values of E6742 up to 800 mg, but these values were slightly less than dose proportional at 10 mg. In the MAD study, the Cmax and AUC(0-12h)ss of E6742 appeared to be almost dose proportionally increased between 100 and 200 mg, while these parameters showed more than a dose proportional increase at 400 mg. In addition to safety and good tolerability, this study demonstrated cytokine concentrations in cultured peripheral blood in response to E6742 were suppressed in a dose-dependent manner. Further clinical studies targeting systemic lupus erythematosus patients are currently underway." @default.
• W4304203434 created "2022-10-11" @default.
• W4304203434 creator A5001074370 @default.
• W4304203434 creator A5006456433 @default.
• W4304203434 creator A5006935534 @default.
• W4304203434 creator A5009340203 @default.
• W4304203434 creator A5022334220 @default.
• W4304203434 creator A5023222140 @default.
• W4304203434 creator A5029445103 @default.
• W4304203434 creator A5051805339 @default.
• W4304203434 creator A5058174325 @default.
• W4304203434 creator A5059729118 @default.
• W4304203434 creator A5065826771 @default.
• W4304203434 creator A5078185837 @default.
• W4304203434 creator A5085639542 @default.
• W4304203434 date "2022-10-11" @default.
• W4304203434 modified "2023-10-06" @default.
• W4304203434 title "First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll‐like Receptors 7 and 8, in Healthy Volunteers" @default.
• W4304203434 cites W1506194577 @default.
• W4304203434 cites W1964133468 @default.
• W4304203434 cites W1978259263 @default.
• W4304203434 cites W1990290004 @default.
• W4304203434 cites W1997102398 @default.
• W4304203434 cites W2004465286 @default.
• W4304203434 cites W2027261088 @default.
• W4304203434 cites W2035121432 @default.
• W4304203434 cites W2058885875 @default.
• W4304203434 cites W2075494813 @default.
• W4304203434 cites W2132847365 @default.
• W4304203434 cites W2134106169 @default.
• W4304203434 cites W2509437552 @default.
• W4304203434 cites W2771291368 @default.
• W4304203434 cites W2918058344 @default.
• W4304203434 cites W2948814328 @default.
• W4304203434 cites W3007628792 @default.
• W4304203434 cites W3010115114 @default.
• W4304203434 cites W3112629806 @default.
• W4304203434 cites W3193906093 @default.
• W4304203434 cites W4225095275 @default.
• W4304203434 doi "https://doi.org/10.1002/cpdd.1176" @default.
• W4304203434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36219471" @default.
• W4304203434 hasPublicationYear "2022" @default.
• W4304203434 type Work @default.
• W4304203434 citedByCount "2" @default.
• W4304203434 countsByYear W43042034342023 @default.
• W4304203434 crossrefType "journal-article" @default.
• W4304203434 hasAuthorship W4304203434A5001074370 @default.
• W4304203434 hasAuthorship W4304203434A5006456433 @default.
• W4304203434 hasAuthorship W4304203434A5006935534 @default.
• W4304203434 hasAuthorship W4304203434A5009340203 @default.
• W4304203434 hasAuthorship W4304203434A5022334220 @default.
• W4304203434 hasAuthorship W4304203434A5023222140 @default.
• W4304203434 hasAuthorship W4304203434A5029445103 @default.
• W4304203434 hasAuthorship W4304203434A5051805339 @default.
• W4304203434 hasAuthorship W4304203434A5058174325 @default.
• W4304203434 hasAuthorship W4304203434A5059729118 @default.
• W4304203434 hasAuthorship W4304203434A5065826771 @default.
• W4304203434 hasAuthorship W4304203434A5078185837 @default.
• W4304203434 hasAuthorship W4304203434A5085639542 @default.
• W4304203434 hasConcept C111113717 @default.
• W4304203434 hasConcept C112705442 @default.
• W4304203434 hasConcept C126322002 @default.
• W4304203434 hasConcept C170493617 @default.
• W4304203434 hasConcept C197934379 @default.
• W4304203434 hasConcept C22979827 @default.
• W4304203434 hasConcept C2776885963 @default.
• W4304203434 hasConcept C2778375690 @default.
• W4304203434 hasConcept C71924100 @default.
• W4304203434 hasConcept C90924648 @default.
• W4304203434 hasConcept C98274493 @default.
• W4304203434 hasConceptScore W4304203434C111113717 @default.
• W4304203434 hasConceptScore W4304203434C112705442 @default.
• W4304203434 hasConceptScore W4304203434C126322002 @default.
• W4304203434 hasConceptScore W4304203434C170493617 @default.
• W4304203434 hasConceptScore W4304203434C197934379 @default.
• W4304203434 hasConceptScore W4304203434C22979827 @default.
• W4304203434 hasConceptScore W4304203434C2776885963 @default.
• W4304203434 hasConceptScore W4304203434C2778375690 @default.
• W4304203434 hasConceptScore W4304203434C71924100 @default.
• W4304203434 hasConceptScore W4304203434C90924648 @default.
• W4304203434 hasConceptScore W4304203434C98274493 @default.
• W4304203434 hasIssue "4" @default.
• W4304203434 hasLocation W43042034341 @default.
• W4304203434 hasLocation W43042034342 @default.
• W4304203434 hasOpenAccess W4304203434 @default.
• W4304203434 hasPrimaryLocation W43042034341 @default.
• W4304203434 hasRelatedWork W1822154343 @default.
• W4304203434 hasRelatedWork W1997101420 @default.
• W4304203434 hasRelatedWork W2074207917 @default.
• W4304203434 hasRelatedWork W2088986153 @default.
• W4304203434 hasRelatedWork W2091460425 @default.
• W4304203434 hasRelatedWork W2477866235 @default.
• W4304203434 hasRelatedWork W2538072326 @default.
• W4304203434 hasRelatedWork W2765994429 @default.
• W4304203434 hasRelatedWork W3097307756 @default.
• W4304203434 hasRelatedWork W3205517375 @default.
• W4304203434 hasVolume "12" @default.
• W4304203434 isParatext "false" @default.

• next